跳至主要内容
临床试验/NCT01499459
NCT01499459Unknown不适用

Efficacy of Exvivo Expanded Autologous Mesenchymal Stem Cell Transplantation Via Peripheral Vein in Patients With Liver Cirrhosis

Saglik Bilimleri Universitesi Gulhane Tip Fakultesi2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2008年6月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
25
试验地点
2
主要终点
clinical improvement

研究概览

简要总结

This study is aiming to investigate the efficacy of autologous mesenchymal stem cell (MSC) transplantation in 25 randomized patients with liver cirrhosis autologous mesenchymal stem cell will be derived from patients' bone marrows and will be infused via peripheral vein. Liver biopsies will be performed in every patient in the beginning and at 6th month.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • radiological, clinical and histopathological diagnosis of liver cirrhosis
  • absence of hepatocellular carcinoma or any malignancies
  • no psychiatric disorder
  • no serous cardiovascular and pulmonary comorbidities
  • serum total bilirubin levels less than 5 mg/dL
  • platelet counts more than 30.000 mm3
  • more than one year follow up period after initiation of antiviral drugs

排除标准

  • alcohol intake in last one year
  • initiation of antiviral medication in last one year
  • systemic diseases

结局指标

主要结局

clinical improvement

时间窗: clinical improvement parameters will be assessed six month after mesenchymal stem cell transplantation

biochemical and hematologic parameters

次要结局

  • liver regeneration(6.th month after MSC transplantation)

研究者

发起方
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
申办方类型
Other
责任方
Principal Investigator
主要研究者

Murat Kantarcioglu

Gulhane Military Medical Academy

Saglik Bilimleri Universitesi Gulhane Tip Fakultesi

研究点 (2)

Loading locations...

相似试验